Sitemap
En
Invest in TEDA
Strategic Opportunities
Industrial Competitiveness
Soft Advantages
Current Location: Home > Invest in TEDA > Industrial Competitiveness > Medicine & Health
Industrial Competitiveness
Healthcare

Overview

·China’s Biggest Insulin and Enzyme Preparations Production Base

·China’s Biggest Instant Food and Portable Water Production Base

·China’s Biggest Vaccine Industrialization Base


Covering Eight Growth Priorities of the Pharmaceutical Industry:

Biomedicine, Chemical Drugs, Traditional Chinese Medicine(TCM), NaturalMedicines, Medical Devices, In-vitro Diagnostics, CRO Services, Biotechnology


In 2021, TEDA saw a output value of 66.54 billion yuanfrom its healthcare industry.


After 30 years of development, five major industrialclusters have been formed in the fields of biomedicine, medical devices,pharmaceutical R&D outsourcing, food and drink, and big health.

Biomedicine

Medical Devices


CRO

Food & Bevearges


Big Health



Medicine & Health


Overview

·China’s Biggest Insulin and Enzyme Preparations Production Base

·China’s Biggest Instant Food and Portable Water Production Base

·China’s Biggest Vaccine Industrialization Base


Covering Eight Growth Priorities of the Pharmaceutical Industry:

Biomedicine, Chemical Drugs, Traditional Chinese Medicine(TCM), NaturalMedicines, Medical Devices, In-vitro Diagnostics, CRO Services, Biotechnology


In 2021, TEDA saw a output value of 66.54 billion yuanfrom its healthcare industry.


After 30 years of development, five major industrialclusters have been formed in the fields of biomedicine, medical devices,pharmaceutical R&D outsourcing, food and drink, and big health.

Biomedicine

Medical Devices


CRO

Food & Bevearges


Big Health



Website Identification Code: 1201160062

Are you sure you want to leave this page?